June 11, 2020
James Chambers, PhD, associate professor of medicine, the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, discusses the benefits of orphan drugs recently found in his study, and explains why orphan drugs are often less cost effective.
Chambers JD, Silver MC, Berklein FC, Cohen JT, Neumann PJ. Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs [published online ahead of print, 2020 Apr 13]. J Gen Intern Med. 2020;10.1007/s11606-020-05805-2. doi:10.1007/s11606-020-05805-2